NASDAQ: TCMDTactile Systems Technology Inc Stock
$30.28+2.28 (+8.14%)
Updated Jun 26, 2026
TCMD Price
$30.28
Fair Value Price
$82.57
Market Cap
$683.00M
52 Week Low
$9.42
52 Week High
$37.77
P/E
34.02x
P/B
3.13x
P/S
1.72x
PEG
1.06x
Dividend Yield
N/A
Revenue
$343.52M
Earnings
$20.30M
Gross Margin
76.4%
Operating Margin
10.23%
Profit Margin
5.9%
Debt to Equity
0.25
Operating Cash Flow
$42M
Beta
1.07
Next Earnings
Aug 3, 2026
Ex-Dividend
N/A
Next Dividend
N/A
TCMD Overview
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine TCMD's potential to beat the market
AStrong Buy
- Stocks with a Zen Rating of Strong Buy (A) had an average return of +32.52% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
TCMD
Ranked#3 of 94
Ranked#3 of 94
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.78 | A | |
| $41.46 | A | |
| $11.63 | A |
Be the first to know about important TCMD news, forecast changes, insider trades & much more!
TCMD News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TCMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TCMD ($30.28) is undervalued by 63.33% relative to our estimate of its Fair Value price of $82.57 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
TCMD ($30.28) is significantly undervalued by 63.33% relative to our estimate of its Fair Value price of $82.57 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
TCMD ($30.28) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TCMD due diligence checks available for Premium users.
Valuation
TCMD fair value
Fair Value of TCMD stock based on Discounted Cash Flow (DCF)
Price
$30.28
Fair Value
$82.57
Undervalued by
63.33%
TCMD ($30.28) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TCMD ($30.28) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TCMD ($30.28) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
TCMD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
34.02x
Industry
20.87x
Market
12.38x
TCMD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TCMD is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
TCMD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.13x
Industry
3.08x
TCMD is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TCMD price to earnings growth (PEG)
For valuing profitable companies with growth potential
TCMD is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
TCMD's financial health
Profit margin
Revenue
$75.3M
Net Income
-$1.8M
Profit Margin
-2.3%
TCMD's Earnings (EBIT) of $35.16M... subscribe to Premium to read more.
Interest Coverage Financials
TCMD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$272.1M
Liabilities
$54.3M
Debt to equity
0.25
TCMD's short-term assets ($152.84M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TCMD's short-term assets ($152.84M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TCMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TCMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$339.0k
Investing
-$7.1M
Financing
-$1.1M
TCMD's operating cash flow ($42.06M)... subscribe to Premium to read more.
Debt Coverage Financials
TCMD vs Medical Device Stocks
Tactile Systems Technology Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.